Sign in

CIK 0001001316

  • Large accelerated filer

TG THERAPEUTICS, INC.

Sign in to watch
Ticker
TGTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
363898269
Phone
+1 212-554-4484
Business address
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
Former names
MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
  1. 4 Grant or award Director acquired 27,048 shares (grant or award)
  2. 4 Grant or award Director acquired 27,048 shares (grant or award)
  3. 4 Grant or award Director acquired 27,048 shares (grant or award)
  4. 4 Grant or award Director acquired 27,048 shares (grant or award)
  5. 4 Grant or award Director acquired 27,048 shares (grant or award)
  6. 4 Open-market sale CFO, Secretary and Treasurer sold 17,654 shares at $8.47 ($149,529)
  7. 4 Open-market buy CEO and President bought 50,000 shares at $7.04 ($351,750)
  8. 4 Grant or award CEO and President acquired 1,179,380 shares (grant or award)
  9. 4 Open-market sale CFO, Secretary and Treasurer sold 37,275 shares at $4.13 ($153,946)
  10. 4 Open-market sale CFO, Secretary and Treasurer sold 47,191 shares at an average $13.21 ($623,303)
  11. 4 Grant or award Director acquired 15,000 shares (grant or award)
  12. 4 Grant or award Director acquired 15,000 shares (grant or award)
  13. 4 Grant or award Director acquired 15,000 shares (grant or award)
  14. 4 Grant or award CEO and President acquired 1,018,011 shares (grant or award)
  15. 4 Grant or award Director acquired 15,000 shares (grant or award)
  16. 4 Grant or award Director acquired 15,000 shares (grant or award)
  17. 4 Grant or award Director acquired 15,000 shares (grant or award)
  18. 4 Open-market sale Director sold 25,071 shares at $13.45 ($337,205)
  19. 4 Open-market sale CFO, Secretary and Treasurer sold 32,006 shares at $8.50 ($272,051)
  20. 4 Grant or award CEO and President acquired 834,877 shares (grant or award)

Page 5 of 18 · 353 filings